- ￥46324
- Biogems
- 300-31-1mg
- 美国
- 2025年07月13日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 规格：
1mg
靶点/蛋白质：QHHGVTKCN ITCSKMTSK IPVALLIHY QQNQASCGK RAIILETRQ HRLFCADPK EQWVKDAMQ HLDRQAAAL TRNG
来源：E. Coli
特异性：Monkey, Mouse, Rat
官网链接：http://www.bio-gems.com/recombinant-proteins/chemokines/recombinant-human-fractalkine-cx3cl1.html
商品关键词：Recombinant Human Fractalkine (CX3CL1),300-31-1mg ,Biogems
简单描述：Fractalkine is a CX3CL chemokine that signals through the CX3CR1 receptor. Fractalkine has been shown to chemoattract monocytes, microglia cells and NK cells. Recombinant human Fractalkine is an 8.5 kDa protein containing 76 amino acid residues, including the four conserved cysteine residues present in CC chemokines.
Purity: Above 98% as determined by SDS-PAGE Analysis.
Biological Activity: Determined by its ability to chemoattract human T cells using a concentration range of 5.0-10.0 ng/ml.
Cell Type: Monocytes and Macrophages, NK and NKT Cells
官网链接: www.annoron.com
办公电话: 010-56256916
官方售后: 400-965-8633
企业QQ: 3198592576、3212874516
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Construction of Recombinant Human Cytomegalovirus
The use of reverse genetics to generate recombinant viruses allows the researcher to investigate the exact functional significance of particular viral genes during the virus life cycle, by means of their deletion or modification in the viral
Assessment of the Recycling of the Membrane-Bound Chemokine, CX3CL1
Fractalkine (CX3 CL1) is a membrane-anchored chemokine whose N-terminus contains a unique CX3 C motif that is cleaved and released. The membrane-bound form functions as an adhesion molecule and the secreted form as a chemotactic factor
Delivery of Recombinant Adenoviruses to Human Saphenous Vein
The human saphenous vein is the most commonly used conduit for coronary artery bypass grafting owing to its ready availability, ease of harvesting, and favorable surgical handling (1 ). However, it suffers from a progressive decline
技术资料暂无技术资料 索取技术资料
